4//SEC Filing
Goeltz II Robert C. 4
Accession 0001724521-24-000030
CIK 0001724521other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 7:40 PM ET
Size
7.0 KB
Accession
0001724521-24-000030
Insider Transaction Report
Form 4
Goeltz II Robert C.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2024-01-23+86,600→ 86,600 totalExercise: $15.44Exp: 2034-01-22→ Common Stock (86,600 underlying) - Award
Common Stock
2024-01-23+21,300→ 73,131 total
Footnotes (2)
- [F1]Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2024, subject to the Reporting Person's continued service to the Company.
- [F2]The option becomes exercisable in 48 equal monthly installments after January 1, 2024, subject to the Reporting Person's continued service to the Company.
Documents
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0001653881
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 7:40 PM ET
- Size
- 7.0 KB